Mania is a core symptom of bipolar disorder involving periods of euphoria. Decreased inhibitory control, increased risk-taking behaviors, and aberrant reward processing are some of the more recognized symptoms of bipolar disorder and are included in the diagnostic criteria for mania. Current drug therapies for mania are frequently intolerable, ineffective, and carry significant risk for side effects. Presently there are no neurobiologically informed therapies that treat or prevent mania. However, using a newly validated technique termed lesion network mapping, researchers demonstrated that focal brain lesions having a causal role in the development of mania in people without a psychiatric history can occur in different brain locations, such as the right orbitofrontal cortex (OFC), right dorsolateral prefrontal cortex (DLPFC), and right inferior temporal gyrus (ITG). This lesion network evidence converges with existing cross-sectional and longitudinal observations in bipolar mania that have identified specific disruptions in network communication between the amygdala and ventro-lateral prefrontal cortex. The OFC is associated with inhibitory control, risk-taking behavior, and reward learning which are major components of bipolar mania. Thus, the association between OFC with mania symptoms, inhibitory control, risk-taking behavior, and reward processing suggests that this region could be targeted using non-invasive brain stimulation.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Young Mania Rating Scale (YMRS)
Timeframe: Change from baseline to 5 Day follow-up
Young Mania Rating Scale (YMRS)
Timeframe: Change from baseline to 1-month follow-up
Young Mania Rating Scale (YMRS)
Timeframe: Change from baseline to 3-month follow-up
Altman Self-Rating Mania Scale (ASRM)
Timeframe: Change from baseline to 5 Day follow-up
Altman Self-Rating Mania Scale (ASRM)
Timeframe: Change from baseline to 1-month follow-up
Altman Self-Rating Mania Scale (ASRM)
Timeframe: Change from baseline to 3-month follow-up
Psychiatric Hospitalizations for Mania Post Study Entry
Timeframe: Cumulative count of hospitalizations for mania from baseline to end of study